Bronchial Epithelial Cultures and Kawasaki Disease
支气管上皮培养与川崎病
基本信息
- 批准号:7599596
- 负责人:
- 金额:$ 19.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-03 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAneurysmAntibodiesAntigensArteriesBase SequenceBlast CellCD8-Positive T-LymphocytesCell Culture SystemCell Culture TechniquesCellsChildChildhoodCiliaCiliated Bronchial Epithelial CellClinicalCollecting CellCoronary AneurysmCoronary arteryCultured CellsCytoplasmic InclusionDeveloped CountriesDeveloping CountriesDevelopmentDiagnosisDiagnostic testsDiseaseElectron MicroscopyEpidemiologic StudiesEpithelialEpithelial CellsEtiologyGenesGeneticGenomeGoalsHeart DiseasesHumanImmune responseImmunoglobulin AImmunoglobulin Variable RegionImmunohistochemistryImmunologicsIn VitroInclusion BodiesIncubatedInfectious AgentInfiltrationLaboratoriesLungMethodsMucocutaneous Lymph Node SyndromeMyocardial InfarctionNucleic AcidsNucleic acid sequencingPathogenesisPatientsPatternPlasma CellsPopulationPrevention therapyReportingResearch ProposalsRespiratory SystemRespiratory tract structureSamplingSequence AnalysisSiteStaining methodStainsSudden DeathSupporting CellSystemTechniquesTestingTimeTissuesTransmission Electron MicroscopyVirus Diseasesbronchial epitheliumdisorder controllight transmissionmacrophagenovelpathogenpreventprotein aggregatepublic health relevancerapid diagnosisresearch studyrespiratoryrespiratory virus
项目摘要
DESCRIPTION (provided by applicant): The goal of this proposal is to develop an in vitro culture system to study the etiology and pathogenesis of Kawasaki Disease (KD). KD is the leading cause of acquired heart disease in children in developed nations, and can result in coronary artery aneurysms, myocardial infarction and sudden death. The etiologic agent of KD is unknown, although clinical and epidemiologic features point to a ubiquitous infectious agent that may cause severe disease in a genetically susceptible population. We found that KD patients harbor oligoclonal (antigen-driven) IgA plasma cells in the coronary arteries and other inflamed tissues. Using the variable regions from the IgA heavy chains, we made synthetic KD antibodies in vitro and used them in immunohistochemistry experiments on acute KD and control tissues. We found that KD synthetic antibodies detected antigen in acute KD but not control tissues. Interestingly, we detected antigen in the ciliated bronchial epithelium of KD patients, indicating that the respiratory tract is the likely portal of entry for the KD agent. Using light and transmission electron microscopy (TEM), we found that this antigen resides in cytoplasmic inclusion bodies consistent with aggregates of protein and associated nucleic acid. We hypothesize that bronchial epithelial cells are the initial site of replication of the KD agent, which then spreads to target tissues such as the coronary arteries. We propose to exploit human ciliated bronchial epithelial cells to cultivate the KD agent in vitro. Our specific aims are to 1) Determine if clinical respiratory samples from acute KD patients infect ciliated bronchial epithelial cell cultures in vitro and 2) Use sequence-independent amplification techniques to amplify, clone and sequence novel nucleic acid sequences from the cell-free supernatant of KD-infected cultures. These studies are exciting because for the first time, a cell likely to contain the KD agent, the ciliated bronchial epithelial cell, has been identified and can be subjected to careful study using electron microscopy and cell culture methods. Developing a cell culture system for the KD agent would allow for remarkable advances in diagnosis, therapy, and prevention of this increasingly recognized and potentially fatal childhood disease. PUBLIC HEALTH RELEVANCE. Kawasaki Disease (KD) is a childhood illness that can result in heart attacks and sudden death, but the cause of the disease is unknown, and therefore there is no specific test to allow for rapid diagnosis. We propose to culture cells from human airways and infect those cells with respiratory samples from KD patients to propagate the KD agent in the laboratory. Our goals are to identify the genetic information of the KD agent from these cells, and to develop a specific diagnostic test so that children with this disease can be diagnosed accurately and treated immediately to prevent fatalities.
描述(由申请方提供):本提案的目的是开发一种体外培养系统,以研究川崎(KD)的病因和发病机制。KD是发达国家儿童获得性心脏病的主要原因,可导致冠状动脉瘤、心肌梗死和猝死。KD的病原体尚不清楚,尽管临床和流行病学特征表明一种普遍存在的感染因子可能在遗传易感人群中引起严重疾病。我们发现KD患者在冠状动脉和其他炎症组织中存在寡克隆(抗原驱动)伊加浆细胞。使用伊加重链的可变区,我们在体外合成KD抗体,并将其用于急性KD和对照组织的免疫组织化学实验。我们发现KD合成抗体在急性KD中检测到抗原,而在对照组织中检测不到。有趣的是,我们在KD患者的纤毛支气管上皮中检测到抗原,表明呼吸道可能是KD因子的进入门户。使用光和透射电子显微镜(TEM),我们发现,这种抗原驻留在细胞质包涵体与蛋白质和相关核酸的聚集体一致。我们假设支气管上皮细胞是KD因子复制的初始位点,然后扩散到靶组织,如冠状动脉。我们建议利用人纤毛支气管上皮细胞在体外培养KD代理。我们的具体目标是:1)确定急性KD患者的临床呼吸道样本是否在体外感染纤毛支气管上皮细胞培养物; 2)使用序列非依赖性扩增技术从KD感染培养物的无细胞上清液中扩增、克隆和测序新的核酸序列。这些研究是令人兴奋的,因为第一次,细胞可能含有KD剂,纤毛支气管上皮细胞,已被确定,并可以进行仔细的研究,使用电子显微镜和细胞培养方法。为KD试剂开发细胞培养系统将使这种日益被认识到的潜在致命儿童疾病的诊断,治疗和预防取得显着进展。公共卫生相关性。川崎(KD)是一种儿童疾病,可导致心脏病发作和猝死,但病因不明,因此没有特异性测试可以快速诊断。我们建议培养来自人类气道的细胞,并用来自KD患者的呼吸道样品感染这些细胞,以在实验室中繁殖KD因子。我们的目标是从这些细胞中识别KD因子的遗传信息,并开发一种特异性诊断测试,以便能够准确诊断患有这种疾病的儿童并立即治疗,以防止死亡。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Morphogenesis of Coronavirus HCoV-NL63 in Cell Culture: A Transmission Electron Microscopic Study.
- DOI:10.2174/1874279300802010052
- 发表时间:2009-01
- 期刊:
- 影响因子:0
- 作者:J. Orenstein;Bridget S Banach;S. Baker
- 通讯作者:J. Orenstein;Bridget S Banach;S. Baker
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan C. Baker其他文献
THE CONVERGENCE OF MULTIPLE MODELS OF MOTIVATION FOR SECOND LANGUAGE LEARNING : GARDNER
第二语言学习多种动机模式的融合:加德纳
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
Maclntyre;Keith MacMaster;Susan C. Baker;Univasitl Colhge d Ca - 通讯作者:
Univasitl Colhge d Ca
A chimeric virus-mouse model system for evaluating the function A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses and inhibition of papain-like proteases of emerging coronaviruses
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Susan C. Baker - 通讯作者:
Susan C. Baker
Overcome imposter syndrome: Contribute to working groups and build strong networks
克服冒名顶替综合症:为工作组做出贡献并建立强大的网络
- DOI:
10.1016/j.biocon.2024.110566 - 发表时间:
2024 - 期刊:
- 影响因子:5.9
- 作者:
Amanda E. Bates;Megan A. Davies;Rick D. Stuart;Natali Lazzari;J. Lefcheck;Scott D. Ling;Camille Mellin;David Mouillot;Anthony T.F. Bernard;Scott Bennett;Christopher J. Brown;Michael T. Burrows;Claire L. Butler;J. Cinner;Ella Clausius;Antonia T. Cooper;Mark John Costello;Lara Denis;Graham J. Edgar;Yann Herrera Fuchs;Olivia J. Johnson;Cesc Gordó;Cyril Hautecoeur;Leah M. Harper;F. Heather;Tyson R. Jones;Anthony C. Markey;E. Oh;Matthew Rose;Paula A. Ruiz;José A. Sanabria;Jasmin M. Schuster;Joanna K. Schmid;Susan C. Baker - 通讯作者:
Susan C. Baker
Timing and frequency are the critical factors affecting the impact of defoliation on long term growth of plantation eucalypts
- DOI:
10.1016/j.foreco.2017.02.004 - 发表时间:
2017-05-01 - 期刊:
- 影响因子:
- 作者:
Jane A. Elek;Susan C. Baker - 通讯作者:
Susan C. Baker
Monoclonal Antibodies From Children With Acute Kawasaki Disease Identify a Common Antigenic Target in Fatal Cases Over 5 Decades
来自急性川崎病患儿的单克隆抗体在50多年的致死病例中识别出一个共同的抗原靶点
- DOI:
10.1016/j.labinv.2025.104131 - 发表时间:
2025-06-01 - 期刊:
- 影响因子:4.200
- 作者:
Anne H. Rowley;Robert Byrd;David Arrollo;Amornrat O’Brien;Stanford Shulman;Masaru Terai;Kwang-Youn Kim;Kassandra Mercado;Kristine Wylie;Robert Fialkowski;Susan C. Baker - 通讯作者:
Susan C. Baker
Susan C. Baker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan C. Baker', 18)}}的其他基金
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10206579 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10882676 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10449132 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10657457 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8099729 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
7987943 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
9096719 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8291352 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8686719 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8485522 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
相似海外基金
Establishment of human abdominal aortic aneurysm wall strength prediction model using Ex Vivo Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging
利用Ex Vivo超顺磁性氧化铁建立人体腹主动脉瘤壁强度预测模型
- 批准号:
23K08226 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Vascular Smooth Muscle Protein Quality Control and Aortic Aneurysm Formation
血管平滑肌蛋白质量控制与主动脉瘤形成
- 批准号:
10714562 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
- 批准号:
10716621 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Role of mechanical heterogeneity in cerebral aneurysm growth and rupture
机械异质性在脑动脉瘤生长和破裂中的作用
- 批准号:
10585539 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Study on development of prophylaxis for recanalization after coil embolization of cerebral aneurysm and elucidation of its mechanisms
脑动脉瘤弹簧圈栓塞术后再通预防措施的研究进展及机制阐明
- 批准号:
23K08512 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Roles of aging and cellular senescence in the development of intracranial aneurysm rupture
衰老和细胞衰老在颅内动脉瘤破裂发展中的作用
- 批准号:
10680060 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Role of Selective Autophagy of Focal Adhesion in Intracranial Aneurysm
局部粘连选择性自噬在颅内动脉瘤中的作用
- 批准号:
10586692 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
- 批准号:
10733477 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Extracellular Vesicle Delivery System for Treatment of Abdominal Aortic Aneurysm
细胞外囊泡递送系统治疗腹主动脉瘤
- 批准号:
10751123 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:














{{item.name}}会员




